425 related articles for article (PubMed ID: 33335181)
1. MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes.
Chelakkot VS; Liu K; Yoshioka E; Saha S; Xu D; Licursi M; Dorward A; Hirasawa K
Sci Rep; 2020 Dec; 10(1):22124. PubMed ID: 33335181
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.
Yoshioka E; Chelakkot VS; Licursi M; Rutihinda SG; Som J; Derwish L; King JJ; Pongnopparat T; Mearow K; Larijani M; Dorward AM; Hirasawa K
Theranostics; 2018; 8(8):2134-2146. PubMed ID: 29721068
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
Mansi M; Howley R; Chandratre S; Chen B
Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
[TBL] [Abstract][Full Text] [Related]
5. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
[TBL] [Abstract][Full Text] [Related]
6. Methods to Measure the Inhibition of ABCG2 Transporter and Ferrochelatase Activity to Enhance Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Tumor Detection and Resection.
Mansi M; Howley R; Chen B
Methods Mol Biol; 2022; 2394():823-835. PubMed ID: 35094360
[TBL] [Abstract][Full Text] [Related]
7. Systemic MEK inhibition enhances the efficacy of 5-aminolevulinic acid-photodynamic therapy.
Chelakkot VS; Som J; Yoshioka E; Rice CP; Rutihinda SG; Hirasawa K
Br J Cancer; 2019 Oct; 121(9):758-767. PubMed ID: 31551581
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract][Full Text] [Related]
9. Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells.
Ogino T; Kobuchi H; Munetomo K; Fujita H; Yamamoto M; Utsumi T; Inoue K; Shuin T; Sasaki J; Inoue M; Utsumi K
Mol Cell Biochem; 2011 Dec; 358(1-2):297-307. PubMed ID: 21748335
[TBL] [Abstract][Full Text] [Related]
10. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.
Teng L; Nakada M; Zhao SG; Endo Y; Furuyama N; Nambu E; Pyko IV; Hayashi Y; Hamada JI
Br J Cancer; 2011 Mar; 104(5):798-807. PubMed ID: 21304523
[TBL] [Abstract][Full Text] [Related]
11. The N-terminal region of p27 inhibits HIF-1α protein translation in ribosomal protein S6-dependent manner by regulating PHLPP-Ras-ERK-p90RSK axis.
Zhang D; Liu J; Mi X; Liang Y; Li J; Huang C
Cell Death Dis; 2014 Nov; 5(11):e1535. PubMed ID: 25412313
[TBL] [Abstract][Full Text] [Related]
12. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation.
Kobuchi H; Moriya K; Ogino T; Fujita H; Inoue K; Shuin T; Yasuda T; Utsumi K; Utsumi T
PLoS One; 2012; 7(11):e50082. PubMed ID: 23189181
[TBL] [Abstract][Full Text] [Related]
14. Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.
Palasuberniam P; Kraus D; Mansi M; Braun A; Howley R; Myers KA; Chen B
Photochem Photobiol; 2019 Jul; 95(4):1052-1059. PubMed ID: 30767226
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
16. Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.
Kemmner W; Wan K; Rüttinger S; Ebert B; Macdonald R; Klamm U; Moesta KT
FASEB J; 2008 Feb; 22(2):500-9. PubMed ID: 17875605
[TBL] [Abstract][Full Text] [Related]
17. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
18. Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization.
Piffaretti D; Burgio F; Thelen M; Kaelin-Lang A; Paganetti P; Reinert M; D'Angelo ML
J Photochem Photobiol B; 2019 Dec; 201():111640. PubMed ID: 31734545
[TBL] [Abstract][Full Text] [Related]
19. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma.
Takai M; Nakagawa T; Tanabe A; Terai Y; Ohmichi M; Asahi M
Cancer Biol Ther; 2015; 16(2):325-35. PubMed ID: 25756515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
